EXTON, Pa., Aug. 25, 2017 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, announced
that management will be presenting a West business overview at
three investor conferences in September.
Management will present at the Baird 2017 Global Healthcare
Conference, at the InterContinental New York Barclay in
New York, N.Y., at 3:10 p.m. EDT on Wednesday, September 6; the 2017 Wells Fargo
Healthcare Conference, at the Westin Boston Waterfront in
Boston, Mass., at 11:10 a.m. EDT on Thursday, September 7; and the Morgan Stanley
Global Healthcare Conference, at the Grand Hyatt in New York, N.Y., at 1:00
p.m. EDT on Wednesday, September
13.
A live audio webcast of each presentation, as well as the
presentation materials, will be accessible from the Company's
website at www.westpharma.com/en/investors.
About West
West Pharmaceutical Services, Inc. is a
leading manufacturer of packaging components and delivery systems
for injectable drugs and healthcare products. Working by the side
of its customers from concept to patient, West creates products
that promote the efficiency, reliability and safety of the world's
pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its
customers from locations in North and South America, Europe, Asia
and Australia. West's 2016 net
sales of $1.5 billion reflect the
daily use of approximately 112 million of its components and
devices, which are designed to improve the delivery of healthcare
to patients around the world.
West and the diamond logo and By your side for a healthier
world™ are registered trademarks or trademarks of West
Pharmaceutical Services, Inc., in the
United States and other jurisdictions.
Investor
Contact:
|
Media
Contact:
|
Quintin
Lai
|
Emily
Denney
|
Vice President,
Investor Relations
|
Vice President,
Global Communications
|
+1-610-594-3318
|
+1-610-594-3035
|
Quintin.Lai@westpharma.com
|
Emily.Denney@westpharma.com
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/west-announces-fall-investor-conference-schedule-300509487.html
SOURCE West Pharmaceutical Services, Inc.